2-Chloro-4-nitropyridine | CAS:23056-36-2

We serve 2-Chloro-4-nitropyridine CAS:23056-36-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Chloro-4-nitropyridine

Chemical Name:2-Chloro-4-nitropyridine
CAS.NO:23056-36-2
Synonyms:2-Chloro-4-nitropyridine
4-nitro-2-chloropyridine
2-Chlor-4-nitro-pyridin
2-chloro-4-nitro-pyridine
Pyridine,2-chloro-4-nitro
Molecular Formula:C5H3ClN2O2
Molecular Weight:158.54300
 
Physical and Chemical Properties:
Density:1.489
Melting point:52-56ºC
Boiling point:258.4ºC
Flash point:223°F
 
Specification:
Appearance:Yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-Chloro-4-nitropyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridine,2-chloro-4-nitro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-chloro-4-nitro-pyridine Use and application,Pyridine,2-chloro-4-nitro technical grade,usp/ep/jp grade.


Related News: Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.4-Amino-3,5-dichlorobenzotrifluoride manufacturer United Airlines — which announced that it will suspend flights to Beijing, Chengdu and Shanghai from February 6 — is also reducing flights from the US to Hong Kong.(1-benzoyl-2-oxo-4-phenylazetidin-3-yl) acetate supplier Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.(3-Chloropropyl)diethoxy(methyl)silane vendor “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.